Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Inventory (2020 - 2025)

SOPHiA GENETICS's Inventory history spans 6 years, with the latest figure at $6.4 million for Q4 2025.

  • On a quarterly basis, Inventory rose 8.23% to $6.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.4 million, a 8.23% increase, with the full-year FY2025 number at $6.4 million, up 8.23% from a year prior.
  • Inventory hit $6.4 million in Q4 2025 for SOPHiA GENETICS, down from $6.7 million in the prior quarter.
  • Over the last five years, Inventory for SOPH hit a ceiling of $6.7 million in Q3 2025 and a floor of $3.7 million in Q2 2021.
  • Historically, Inventory has averaged $5.6 million across 5 years, with a median of $5.8 million in 2022.
  • Biggest five-year swings in Inventory: surged 69.3% in 2021 and later decreased 19.64% in 2023.
  • Tracing SOPH's Inventory over 5 years: stood at $5.7 million in 2021, then fell by 10.0% to $5.2 million in 2022, then rose by 25.72% to $6.5 million in 2023, then dropped by 9.47% to $5.9 million in 2024, then increased by 8.23% to $6.4 million in 2025.
  • Business Quant data shows Inventory for SOPH at $6.4 million in Q4 2025, $6.7 million in Q3 2025, and $6.2 million in Q2 2025.